Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.

NCT02141230 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Weight Loss

Interventions

DRUG: Alli® 60 mg

Sponsor

GlaxoSmithKline

Collaborators

[object Object]